A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 6, Issue 5, Pages e1767-e1767
Publisher
Springer Nature
Online
2015-05-21
DOI
10.1038/cddis.2015.130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
- (2015) Manuele Rebsamen et al. NATURE
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- TAK1 control of cell death
- (2014) S R Mihaly et al. CELL DEATH AND DIFFERENTIATION
- RIP kinases: key decision makers in cell death and innate immunity
- (2014) F Humphries et al. CELL DEATH AND DIFFERENTIATION
- TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation
- (2014) Sho Morioka et al. JOURNAL OF CELL BIOLOGY
- RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
- (2014) Pratyusha Mandal et al. MOLECULAR CELL
- Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
- (2014) Huayi Wang et al. MOLECULAR CELL
- Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
- (2014) Kilian V. M. Huber et al. NATURE
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death
- (2014) Joanne M. Hildebrand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
- (2014) W. J. Kaiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
- (2014) K. Newton et al. SCIENCE
- A Plug Release Mechanism for Membrane Permeation by MLKL
- (2014) Lijing Su et al. STRUCTURE
- The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
- (2014) J-X Li et al. Cell Death & Disease
- MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
- (2014) Yves Dondelinger et al. Cell Reports
- RIPK3-Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival
- (2013) A. Lau et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Necroptosis in Immunity and Ischemia-Reperfusion Injury
- (2013) A. Linkermann et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Control of Life-or-Death Decisions by RIP1 Kinase
- (2013) Dana E Christofferson et al. Annual Review of Physiology
- Crosstalk between apoptosis, necrosis and autophagy
- (2013) Vassiliki Nikoletopoulou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration
- (2013) Y Murakami et al. CELL DEATH AND DIFFERENTIATION
- Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death
- (2013) Xin Chen et al. CELL RESEARCH
- Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
- (2013) Agnieszka Kaczmarek et al. IMMUNITY
- Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
- (2013) William J. Kaiser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
- (2013) Zhenyu Cai et al. NATURE CELL BIOLOGY
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
- (2013) J.E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury
- (2013) A. Linkermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases
- (2013) R. J. Thapa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis
- (2013) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development
- (2013) Juan Lin et al. Cell Reports
- Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo
- (2012) Martinus I. F. J. Oerlemans et al. BASIC RESEARCH IN CARDIOLOGY
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
- (2012) Jixi Li et al. CELL
- DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA
- (2012) Jason W. Upton et al. Cell Host & Microbe
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
- (2012) Jorge E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Programmed Cell Death in Animal Development and Disease
- (2011) Yaron Fuchs et al. CELL
- An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance
- (2011) J. Zuber et al. GENES & DEVELOPMENT
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration
- (2011) Chris Jopling et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway
- (2011) S. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus Inhibition of RIP3-Dependent Necrosis
- (2010) Jason W. Upton et al. Cell Host & Microbe
- Pazopanib in Renal Cell Carcinoma
- (2010) J. E. Ward et al. CLINICAL CANCER RESEARCH
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Modeling Contaminants in AP-MS/MS Experiments
- (2010) Mathieu Lavallée-Adam et al. JOURNAL OF PROTEOME RESEARCH
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- (2009) YoungSik Cho et al. CELL
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
- (2009) Sudan He et al. CELL
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-κB
- (2009) Manuele Rebsamen et al. EMBO REPORTS
- Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
- (2009) Thomas E. Hutson et al. JOURNAL OF CLINICAL ONCOLOGY
- Target profiling of small molecules by chemical proteomics
- (2009) Uwe Rix et al. Nature Chemical Biology
- RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
- (2009) D.-W. Zhang et al. SCIENCE
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
- (2008) L L Remsing Rix et al. LEUKEMIA
- Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib
- (2008) Oliver Hantschel et al. LEUKEMIA & LYMPHOMA
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started